Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412
Keywords: Familial mastocytosis; K509I KIT mutation; Tyrosine kinase inhibitors; Imatinib; Dasatinib; PKC412;